Jeff Bezos has had quite a hectic week, having just concluded his third venture capital investment in a promising artificial intelligence startup. This time, the recipient of Bezos’s largesse is a ...

As we age, the composition and function of proteins in the brain change, affecting how well our brain performs later in ...

Jefferies London Healthcare Conference 2025 November 20, 2025 7:30 AM ESTCompany ParticipantsJames Hippel - Executive VP ...

RBC Capital analyst Leonid Timashev upgraded Design Therapeutics (DSGN) to Outperform from Sector Perform with a price target of $13, up from $6.

A single multipurpose gene-editing tool can correct several genetic conditions by restoring proteins that have been truncated ...

Created by leaders of a Salesforce skunkworks, this East Bay AI company just raised $106 million from Jeff Bezos and others.

The Jacobs School of Medicine and Biomedical Sciences’ use of artificial intelligence (AI) is transforming its medical research landscape by accelerating discovery, improving accuracy and enabling ...

Enanta Pharmaceuticals, Inc.'s strong pipeline, positive RSV drug data, and solid cash position drive growth. Click for my ...

At HUPO 2025, ETH Zurich’s Prof. Paola Picotti discussed how limited proteolysis mass spectrometry tracks protein shape ...

As the global population races towards 9.7 billion by 2050, the world’s protein supply – an essential nutrient that builds ...

A mini-peptide has been created that delays the early damage caused by Parkinson's disease and promises a way to slow down ...

Eleva’s CEO says CHO cell line alternatives could become common as large molecule drugs become complex and harder to produce ...